Harvard Medical School, MIT, Boston, USA

Dr. Sexauer is a graduate of the Johns Hopkins University, School of Medicine. She completed her residency at the Children’s Hospital of Philadelphia and was followed later a fellowship at the Dana-Farber Cancer Institute and Boston Children’s Hospital. She has the American Board Certification in Pediatrics. Dr Sexauer studies the process of normal hematopoietic differentiation and its perturbations in both myeloid and lymphoid malignancies. Her goal as an academic physician-scientist is to continue to develop new combination therapies for children with high-risk leukemias to improve survival and minimize long-term toxicity. Her clinical interests involve: Adolescents and young adult oncology, Hematologic malignancies and Novel therapies and she is specialized in the treatments of Bone Marrow Failure, Childhood Leukemias, Childhood Lymphomas and Childhood Myelodysplastic Syndrome (MDS).